Standout Papers

Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma 2021 2026 2022 2024209
  1. Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma (2021)
    David A. Braun, Ziad Bakouny et al. Nature Reviews Clinical Oncology

Immediate Impact

9 by Nobel laureates 60 standout
Sub-graph 1 of 22

Citing Papers

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
2 intermediate papers

Works of Laure Hirsch being referenced

Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma
2021 Standout

Author Peers

Author Last Decade Papers Cites
Laure Hirsch 284 231 172 16 481
Linda Mahjoubi 362 203 207 12 543
Daniele Pozzessere 226 170 111 24 416
Henk Mallo 231 182 167 24 441
Lambert J. C. M. Van den Broek 123 194 170 14 537
Chang Shu Wang 234 169 133 15 551
Xiliang Cong 274 147 125 14 464
Katherine A. Scilla 348 278 129 24 553
Coraline Duménil 416 228 122 20 533
Giorgia Guaitoli 223 160 140 27 420
Brenda Dickow 210 273 159 20 436

All Works

Loading papers...

Rankless by CCL
2026